Adam Kahleifeh, PharmD, BCOP
Advertisement
Articles by Adam Kahleifeh, PharmD, BCOP
Explore how combining BTK inhibitors with CAR T-cell therapy enhances treatment efficacy for B-cell malignancies while managing potential toxicities.
Adam Kahleifeh, PharmD, BCOP, discusses the impact of IDH mutations in low-grade gliomas.
Advertisement
Latest Updated Articles
Current Pneumococcal Vaccination Recommendations: A Clinical UpdatePublished: February 1st 2026 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
3
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
4
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
5